(Q45405547)

14 December 2017

title

Case report of 3 patients with severe mental illness and chronic hepatitis C virus infection treated with interferon-alpha (English)

1 reference

14 December 2017

1 reference

1 reference

Lisa A Mistler

1

1 reference

14 December 2017

Mary F Brunette

2

1 reference

14 December 2017

Stanley D Rosenberg

3

1 reference

14 December 2017

Robert M Vidaver

4

1 reference

14 December 2017

Ravi Luckoor

5

1 reference

14 December 2017

Mark Iber

6

1 reference

14 December 2017

publication date

1 January 2006

1 reference

International Journal of Psychiatry in Medicine

14 December 2017

published in

1 reference

14 December 2017

volume

36

1 reference

14 December 2017

issue

4

1 reference

14 December 2017

page(s)

449-455

1 reference

Prevalence of HIV, hepatitis B, and hepatitis C in people with severe mental illness.

14 December 2017

cites work

1 reference

https://api.crossref.org/works/10.2190%2F1336-74M1-1718-73G1

Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2F1336-74M1-1718-73G1

Hepatitis C treatment for people with severe mental illness

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2F1336-74M1-1718-73G1

Understudied populations with hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2F1336-74M1-1718-73G1

Psychiatric illness and illicit drugs as barriers to hepatitis C treatment among HIV/hepatitis C virus co-infected individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2F1336-74M1-1718-73G1

Hepatitis C virus and human immunodeficiency virus coinfection in an urban population: low eligibility for interferon treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2F1336-74M1-1718-73G1

Bipolar disorder associated with interferon-alpha treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2F1336-74M1-1718-73G1

A case of interferon alpha-induced manic psychosis in chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2F1336-74M1-1718-73G1

Adherence and mental side effects during hepatitis C treatment with interferon alfa and ribavirin in psychiatric risk groups

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2F1336-74M1-1718-73G1

Risk factors for severe neuropsychiatric toxicity in patients receiving interferon alfa-2b and low-dose cytarabine for chronic myelogenous leukemia: analysis of Cancer and Leukemia Group B 9013

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2F1336-74M1-1718-73G1

Schizophrenic psychosis: a contraindication for treatment of hepatitis C with interferon alpha?

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2F1336-74M1-1718-73G1

10.2190/1336-74M1-1718-73G1

21 January 2018

Identifiers

DOI

1 reference

14 December 2017

1 reference